PSP Society of Canada progressive supranuclear palsy
  • Home
  • Search
  • Menu Canvas
    • Home
    • Causes
      • Causes Slide
      • Causes Slide 2
      • Causes Slide 3
      • Causes Grid
    • Events
      • Events Slide
      • Events Special
    • Projects
      • Projects Grid
    • Shop
      • Checkout
      • My account
    • News
      • Posts Slide
      • Posts Slide 2
      • Latest News
    • About Us
    • Contact
    • Sidebar

      Instagram

      Please check the widget data

      Tags

      Disease foundation michael j fox Neurodegenerative Proteins Treatment
  • DONATE NOW
PSP Society of Canada progressive supranuclear palsy
Email
info@pspsocietycanada.ca
Call Now
1.888.675.0230
  • Home
  • About Us
  • Donate
  • Events
  • News
  • Contact

News

Homepage Blog
Education

Biogen Announces Phase 2 PASSPORT Study Results: Further Development of Gosuranemab in PSP Will Not be Pursued
December 14, 2019
By admin

Biogen Announces Phase 2 PASSPORT Study Results:  Further Development of Gosuranemab in PSP Will Not be Pursued Biogen today announced… more

Read More
Education

Rethinking Neurodegenerative Disease Treatment: Target Multiple Pathological Proteins, Not Just One
October 18, 2018
By admin

Penn study finds multiple ‘proteinopathies’ present in most neurodegenerative diseases, expanding treatment to target more of them may prove successful.… more

Read More
http://markets.businessinsider.com/news/stocks/Michael-J-Fox-Foundation-and-Tau-Consortium-Announce-Partnership-to-Develop-New-Imaging-Tools-for-Devastating-Neurodegenerative-Diseases-1005453850
Charity, Education, News

Michael J. Fox Foundation and Tau Consortium Announce Partnership to Develop New Imaging Tools for Devastating Neurodegenerative Diseases
October 26, 2017
By admin
0
675
Read More

Recent Post

  • Biogen Announces Phase 2 PASSPORT Study Results: Further Development of Gosuranemab in PSP Will Not be Pursued Saturday, 14, Dec
  • Rethinking Neurodegenerative Disease Treatment: Target Multiple Pathological Proteins, Not Just One Thursday, 18, Oct
  • Michael J. Fox Foundation and Tau Consortium Announce Partnership to Develop New Imaging Tools for Devastating Neurodegenerative Diseases Thursday, 26, Oct

Recent Comments

    Meta

    • Log in
    • Entries RSS
    • Comments RSS
    • WordPress.org

    Tags

    Disease foundation michael j fox Neurodegenerative Proteins Treatment

    About Us

    The PSP Society of Canada serves patients and families dealing with Progressive Supranuclear Palsy (PSP) and related diseases such as Multiple System Atrophy (MSA) and Corticobasal Degeneration (CBD).  

    Contact Info

    Contact Us

    PO Box 40, Station Main
    Kingston, ON    K7L 4V6

    info@pspsocietycanada.ca

    News

    • Biogen Announces Phase 2 PASSPORT Study Results: Further Development of Gosuranemab in PSP Will Not be Pursued Saturday, 14, Dec
    • Rethinking Neurodegenerative Disease Treatment: Target Multiple Pathological Proteins, Not Just One Thursday, 18, Oct
    • Michael J. Fox Foundation and Tau Consortium Announce Partnership to Develop New Imaging Tools for Devastating Neurodegenerative Diseases Thursday, 26, Oct

    Tags

    Disease foundation michael j fox Neurodegenerative Proteins Treatment
    Copyright ©2017 PSP Society of Canada. All Rights Reserved
    Search